Omeros OMER
NASDAQ OMER
$19.05 -0.06 (-0.31%)
As of: Sep 4, 2026 · 2:31 PM EDT

Omeros (OMER) Enterprise Value (2010 - 2026)

Omeros (OMER) posted Enterprise Value of -$135.3 million for Q1 2026, up 21.24% sequentially from -$171.8 million in Q4 2025, and down 158.18% YoY from $232.6 million in Q1 2025.

Analysis

Omeros (OMER) Enterprise Value (2010 - 2026) Analysis & Trends

Omeros has reported Enterprise Value for 17 years, with the latest figure at -$135.3 million in Q1 2026.

  • Quarterly Enterprise Value fell 158.18% year-over-year to -$135.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$135.3 million (down 158.18% YoY) and the FY2025 annual result came in at -$171.8 million, down 90.61% from the prior year.
  • Enterprise Value advanced to -$135.3 million in Q1 2026 per OMER's latest filing, from -$171.8 million in the prior quarter.
  • Over five years, Enterprise Value peaked at -$52.4 million in Q1 2025 and troughed at -$590.0 million in Q3 2023.
  • A 5-year average of -$204.2 million and a median of -$158.9 million in 2024 frame the typical range for Enterprise Value.
  • The sharpest annual moves came in 2023 and 2025: Enterprise Value tumbled 178.53% in 2023, then jumped 88.58% in 2025.
  • Over 5 years, Enterprise Value stood at -$194.9 million in 2022, then rose by 11.84% to -$171.8 million in 2023, then jumped by 47.55% to -$90.1 million in 2024, then slumped by 90.61% to -$171.8 million in 2025, then advanced by 21.24% to -$135.3 million in 2026.
  • According to Business Quant data, Enterprise Value over the past three periods registered -$135.3 million, -$171.8 million, and -$69.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.78 Bn 130.92 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.50 Bn 77.51 Bn 3.93 Bn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn
4 Moderna 58.06 Bn 52.92 Bn 52.00 Mn
5 Revolution Medicines 44.04 Bn 44.04 Bn -
6 BeOne Medicines 40.04 Bn 34.94 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn
8 Royalty Pharma 28.41 Bn 27.57 Bn -
9 Insmed 27.42 Bn 26.26 Bn 358.27 Mn
10 Omeros 1.37 Bn 1.37 Bn 27.73 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 553.60 Mn
Mar 31, 2026 624.99 Mn
Dec 31, 2025 1.06 Bn
Sep 30, 2025 217.51 Mn
Jun 30, 2025 124.53 Mn
Mar 31, 2025 376.74 Mn
Dec 31, 2024 483.35 Mn
Sep 30, 2024 -14.78 Mn
Jun 30, 2024 -80.44 Mn
Mar 31, 2024 -258.90 Mn
Dec 31, 2023 28.04 Mn
Sep 30, 2023 -406.40 Mn
Jun 30, 2023 -334.09 Mn
Mar 31, 2023 -446.77 Mn
Dec 31, 2022 -52.92 Mn
Sep 30, 2022 -98.83 Mn
Jun 30, 2022 -58.52 Mn
Mar 31, 2022 101.54 Mn
Dec 31, 2021 245.44 Mn
Sep 30, 2021 769.10 Mn